Key points are not available for this paper at this time.
Introduction:Epidermolysis Bullosa (EB) is a congenital, rare, chronic, systemic, serious, non-contagious and autoimmune condition, considered a mechanobullous dermatosis.Characteristically, affected individuals develop vesicles or blisters on the skin and mucous membranes, spontaneously or after minimal trauma.Therefore, EB appears to be a relevant topic for scientific investigations.Objective: Understand the pathophysiological aspects, causes, symptoms, diagnosis and treatment of epidermolysis bullosa, as well as its clinical implications.Methodology: The present study is a bibliographic review article related to Epidermolysis Bullosa, carried out between June and August
Neto et al. (Fri,) studied this question.